Zantac Maximum Strength 150 mg Oral Tablet
RxNorm 827189
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 827189 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Zantac Maximum Strength 150 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Ranitidine 150 mg Oral Tablet [Zantac]
(Atom ID: 12365198)
SY
Synonym (SY):
Zantac 150 mg (as ranitidine hydrochloride 168 mg) Oral Tablet
(Atom ID: 8247319)
SY
Synonym (SY):
Zantac 150 mg Oral Tablet
(Atom ID: 2935360)
PSN
Prescribable Name (PSN):
Zantac Maximum Strength 150 mg Oral Tablet
(Atom ID: 6363251)
Patient Education
Ranitidine
Ranitidine is used to treat ulcers; gastroesophageal reflux disease (GERD), a condition in which backward flow of acid from the stomach causes heartburn and injury of the food pipe (esophagus); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. Over-the-counter ranitidine is used to prevent and treat symptoms of heartburn associated with acid indigestion and sour stomach. Ranitidine is in a class of medications called H2 blockers. It decreases the amount of acid made in the stomach.
[Learn More]
* Please review the disclaimer below.